Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Athos Capital

Latest statistics and disclosures from Athos Capital's latest quarterly 13F-HR filing:

Top 5 stock holdings are KVUE, MOMO, BEKE, RNA, HOLX, and represent 65.57% of Athos Capital's stock portfolio.
Added to shares of these 10 stocks: MOMO (+$47M), KVUE (+$17M), RNA (+$13M), HOLX (+$13M), CWAN (+$12M), CDTX (+$8.8M), FOLD (+$8.5M), JHG, CFLT, RNW.
Started 12 new stock positions in JHG, RNA, CWAN, MOMO, PIIIW, HOLX, CFLT, RNW, ASBPW, BL. FOLD, CDTX.
Reduced shares in these 10 stocks: MRUS (-$7.5M), PZZA, K, , BEKE, IPG, GTLS, CHA, TXNM, LBRDK.
Sold out of its positions in CORZ, IPG, K, PZZA, Pinnacle Financial Partners, SOHU, MRUS.
Athos Capital was a net buyer of stock by $111M.
Athos Capital has $261M in assets under management (AUM), dropping by 63.45%.
Central Index Key (CIK): 0001681662

Tip: Access up to 7 years of quarterly data

Positions held by Athos Capital consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Athos Capital

Athos Capital holds 37 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Kenvue (KVUE)	22.9	$60M	+38%	3.5M	17.25	View chart
Hello Group Ads (MOMO)	18.2	$47M	NEW	7.2M	6.55	View chart
Ke Hldgs Sponsored Ads (BEKE)	14.6	$38M	-3%	2.4M	15.76	View chart
Avidity Biosciences Ord (RNA)	5.1	$13M	NEW	185k	72.13	View chart
Hologic (HOLX)	4.9	$13M	NEW	170k	74.49	View chart
Clearwater Analytics Hldgs I Cl A Call Option (CWAN)	4.6	$12M	NEW	500k	24.12	View chart
Chart Industries (GTLS)	4.4	$12M	-3%	56k	206.23	View chart
Cidara Therapeutics Com New (CDTX)	3.4	$8.8M	NEW	40k	220.90	View chart
Amicus Therapeutics (FOLD)	3.3	$8.5M	NEW	600k	14.24	View chart
PNM Resources (TXNM)	3.1	$8.1M	-3%	138k	58.88	View chart
Liberty Broadband Corp Com Ser C (LBRDK)	3.0	$7.9M	-3%	164k	48.60	View chart
Norfolk Southern (NSC)	2.1	$5.6M	-3%	19k	288.71	View chart
Janus Henderson Group Ord Shs (JHG)	1.5	$4.0M	NEW	85k	47.56	View chart
Joyy Ads Repstg Com A (JOYY)	1.4	$3.8M	-2%	58k	64.77	View chart
Confluent Class A Com (CFLT)	1.3	$3.4M	NEW	114k	30.24	View chart
Renew Energy Global Cl A Shs (RNW)	1.1	$2.9M	NEW	507k	5.65	View chart
Taskus Class A Com (TASK)	1.1	$2.8M	+66%	241k	11.79	View chart
Fact Ii Acquisition Corp Unit 99/99/9999 (FACTU)	1.0	$2.6M		250k	10.51	View chart
Chagee Hldgs Sponsored Ads (CHA)	0.6	$1.7M	-16%	145k	11.63	View chart
Dynamix Corp Unit 10/25/2029 (ETHMU)	0.5	$1.4M		125k	10.89	View chart
Blackline (BL)	0.4	$1.1M	NEW	20k	55.30	View chart
Bold Eagle Acquisition Corp Unit 99/99/9999 (BEAGU)	0.4	$1.1M		100k	10.60	View chart
Oaktree Acquisition Corp Iii Unit 10/04/2029 (OACCU)	0.2	$536k		50k	10.72	View chart
Huya Ads Rep Shs A (HUYA)	0.1	$389k	-2%	135k	2.88	View chart
Lanvin Group Holdings Limite *w Exp 01/14/202 (LANV.WS)	0.1	$317k		158k	2.01	View chart
Legato Merger Corp Iii Unit 99/99/9999 (LEGT.U)	0.1	$282k		25k	11.28	View chart
Churchill Capital Corp Ix Unit 99/99/9999 (CCIXU)	0.1	$266k		25k	10.64	View chart
Ecarx Holdings *w Exp 99/99/999 (ECXWW)	0.1	$159k		92k	1.72	View chart
Douyu Intl Hldgs Sponsored Ads (DOYU)	0.1	$143k	-2%	21k	6.79	View chart
Generation Essentials Group *w Exp 02/15/202 (TGE.WS)	0.0	$87k		83k	1.04	View chart
Sunpower *w Exp 07/31/202 (SPWRW)	0.0	$44k		28k	1.55	View chart
Stardust Pwr *w Exp 06/21/202 (SDSTW)	0.0	$35k		11k	3.08	View chart
Murano Global Invts *w Exp 03/19/202 (MRNOW)	0.0	$25k		43k	0.58	View chart
Envoy Medical *w Exp 09/29/202 (COCHW)	0.0	$19k		29k	0.66	View chart
Captivision *w Exp 11/15/202 (CAPTW)	0.0	$11k		32k	0.34	View chart
P3 Health Partners *w Exp 11/19/202 (PIIIW)	0.0	$3.0k	NEW	37k	0.08	View chart
Aspire Biopharma Hldgs *w Exp 02/14/203 (ASBPW)	0.0	$3.0k	NEW	21k	0.14	View chart

Past Filings by Athos Capital

SEC 13F filings are viewable for Athos Capital going back to 2017

Athos Capital 2025 Q4 filed Feb. 12, 2026
Athos Capital 2025 Q3 filed Nov. 13, 2025
Athos Capital 2025 Q2 filed Aug. 14, 2025
Athos Capital 2025 Q1 filed May 14, 2025
Athos Capital 2024 Q4 filed Feb. 13, 2025
Athos Capital 2024 Q3 filed Nov. 14, 2024
Athos Capital 2024 Q2 filed Aug. 14, 2024
Athos Capital 2024 Q1 filed May 14, 2024
Athos Capital 2023 Q3 filed Nov. 14, 2023
Athos Capital 2023 Q2 filed Aug. 14, 2023
Athos Capital 2023 Q1 filed May 11, 2023
Athos Capital 2022 Q4 filed Feb. 13, 2023
Athos Capital 2022 Q3 filed Nov. 14, 2022
Athos Capital 2022 Q2 filed Aug. 12, 2022
Athos Capital 2022 Q1 filed May 12, 2022
Athos Capital 2021 Q4 restated filed Feb. 17, 2022

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z